Notify me when COURAGE CAPITAL MANAGEMENT LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 13 | $72,356,000 | +$381,149 | -$1,489,144 | -$1,107,995 | BKLN, FBTC, CXW, PHYS, AAAU | 13F-HR | 17 Feb 2026, 16:02 |
| Q3 2025 | 14 | $75,685,000 | +$3,391,402 | $0 | +$3,391,402 | FBTC, BKLN, CXW, PHYS, AAAU | 13F-HR | 12 Nov 2025, 10:18 |
| Q2 2025 | 13 | $67,804,000 | +$16,135,389 | -$1,251,000 | +$14,884,389 | FBTC, BKLN, CXW, PHYS, AAAU | 13F-HR | 15 Aug 2025, 09:13 |
| Q1 2025 | 12 | $48,974,000 | +$1,605,055 | -$1,758,034 | -$152,979 | BKLN, CXW, PHYS, FBTC, AAAU | 13F-HR | 14 May 2025, 11:38 |
| Q4 2024 | 12 | $48,458,000 | +$3,725,864 | -$363,000 | +$3,362,864 | BKLN, CXW, FBTC, PHYS, AAAU | 13F-HR | 14 Feb 2025, 10:42 |
| Q3 2024 | 11 | $40,363,000 | +$4,201,852 | -$5,513,000 | -$1,311,148 | BKLN, PHYS, CXW, AAAU, META | 13F-HR | 14 Nov 2024, 17:51 |
| Q2 2024 | 12 | $39,607,000 | +$5,362,168 | -$252,133 | +$5,110,035 | BKLN, Coherus Biosciences Inc, CXW, PHYS, AAAU | 13F-HR | 14 Aug 2024, 18:08 |
| Q1 2024 | 12 | $34,525,000 | +$13,253,000 | -$5,967,625 | +$7,285,375 | CXW, BKLN, Coherus Biosciences Inc, PHYS, AAAU | 13F-HR | 10 May 2024, 15:02 |
| Q4 2023 | 11 | $24,775,000 | +$354,000 | -$6,142,600 | -$5,788,600 | Coherus Biosciences Inc, PHYS, Evolent Health Inc, AAAU, META | 13F-HR | 12 Feb 2024, 10:48 |
| Q3 2023 | 12 | $29,484,000 | $0 | -$6,182,250 | -$6,182,250 | Coherus Biosciences Inc, PHYS, Coherus Biosciences Inc, AAAU, META | 13F-HR | 08 Nov 2023, 16:48 |
| Q2 2023 | 17 | $36,431,000 | +$3,111,838 | -$7,031,195 | -$3,919,357 | Coherus Biosciences Inc, PHYS, General Dynamics Corp, AAAU, META | 13F-HR | 14 Aug 2023, 16:50 |
| Q1 2023 | 17 | $41,711,000 | +$5,430,084 | -$2,558,000 | +$2,872,084 | Coherus Biosciences Inc, General Dynamics Corp, AAAU, PHYS, BRY | 13F-HR | 15 May 2023, 10:49 |
| Q4 2022 | 18 | $35,596,000 | +$1,203,000 | -$9,435,155 | -$8,232,155 | Coherus Biosciences Inc, Evolent Health Inc, AAAU, PHYS, MSFT | 13F-HR | 13 Feb 2023, 18:42 |
| Q3 2022 | 18 | $46,172,000 | +$3,694,500 | -$20,147,354 | -$16,452,854 | Coherus Biosciences Inc, Evolent Health Inc, AAAU, CHRD, PDCE | 13F-HR | 14 Nov 2022, 14:14 |
| Q2 2022 | 22 | $60,837,000 | +$23,087,516 | -$61,247,920 | -$38,160,404 | Coherus Biosciences Inc, Evolent Health Inc, CHK, WLL, CEIX | 13F-HR | 12 Aug 2022, 14:42 |
| Q1 2022 | 34 | $104,787,000 | +$21,020,460 | -$61,013,749 | -$39,993,289 | Coherus Biosciences Inc, Evolent Health Inc, CHK, MSFT, GOOG | 13F-HR | 16 May 2022, 15:10 |
| Q4 2021 | 38 | $149,344,000 | +$10,199,274 | -$40,560,636 | -$30,361,362 | Coherus Biosciences Inc, Evolent Health Inc, EXC, EVH, Evolent Health Inc | 13F-HR | 14 Feb 2022, 15:19 |
| Q3 2021 | 40 | $185,262,000 | +$45,939,979 | -$27,819,824 | +$18,120,155 | Coherus Biosciences Inc, Evolent Health Inc, Evolent Health Inc, BCEI, EVH | 13F-HR | 15 Nov 2021, 12:27 |
| Q2 2021 | 38 | $166,575,000 | +$82,061,229 | -$69,719,862 | +$12,341,367 | Coherus Biosciences Inc, Evolent Health Inc, CHRD, EVH, VEI | 13F-HR | 13 Aug 2021, 11:43 |
| Q1 2021 | 40 | $136,856,000 | +$53,639,474 | -$10,093,194 | +$43,546,280 | CHRD, CHK, EVOLENT HEALTH INC, EVOLENT HEALTH INC, VTRS | Restatement | 18 May 2021, 11:45 |
| Q4 2020 | 31 | $81,069,000 | +$42,864,778 | -$31,667,540 | +$11,197,238 | CHRD, Evolent Health Inc, VTRS, CCI, EVH | 13F-HR | 16 Feb 2021, 08:54 |
| Q3 2020 | 28 | $64,460,000 | +$22,958,041 | -$7,822,957 | +$15,135,084 | Evolent Health Inc, MYL, CCI, EVH, Centene Corp. | 13F-HR | 16 Nov 2020, 10:31 |
| Q2 2020 | 24 | $48,322,000 | +$22,159,200 | -$20,779,944 | +$1,379,256 | MYL, Evolent Health Inc, CCI, HCA, HNGR | 13F-HR | 14 Aug 2020, 09:51 |
| Q1 2020 | 26 | $44,262,000 | +$33,616,056 | -$10,056,632 | +$23,559,424 | MYL, Centene Corp., HCA, UNH, ELV | 13F-HR | 15 May 2020, 13:40 |
| Q4 2019 | 13 | $33,094,000 | +$3,752,930 | -$33,081,000 | -$29,328,070 | VER, MYL, CPRI, AMZN, META | 13F-HR | 14 Feb 2020, 10:25 |
| Q3 2019 | 16 | $62,403,000 | +$3,319,000 | -$1,953,938 | +$1,365,062 | HNGR, VER, UNH, ACHC, CPRI | 13F-HR | 14 Nov 2019, 11:18 |
| Q2 2019 | 14 | $58,900,000 | +$8,295,528 | -$67,160,392 | -$58,864,864 | HNGR, VER, UNH, CPRI, META | 13F-HR | 14 Aug 2019, 10:48 |
| Q1 2019 | 14 | $116,493,000 | +$3,774,000 | -$30,954,981 | -$27,180,981 | AABA, HNGR, VER, GOOG, ACHC | 13F-HR | 14 May 2019, 11:20 |
| Q4 2018 | 16 | $126,263,000 | +$812,370 | -$20,074,246 | -$19,261,876 | HNGR, AABA, VER, ACHC, GOOG | 13F-HR | 14 Feb 2019, 14:43 |
| Q3 2018 | 20 | $171,257,000 | +$60,642,377 | -$16,891,359 | +$43,751,018 | HNGR, AABA, ACHC, VER, GOOG | 13F-HR | 14 Nov 2018, 09:33 |
| Q2 2018 | 24 | $128,820,000 | +$9,742,905 | -$9,665,053 | +$77,852 | AABA, ACHC, VER, NVCR, GOOG | 13F-HR | 14 Aug 2018, 10:14 |
| Q1 2018 | 25 | $124,825,000 | +$13,918,394 | -$30,205,317 | -$16,286,923 | AABA, VER, ACHC, GOOG, NVCR | 13F-HR | 14 May 2018, 15:14 |
| Q4 2017 | 24 | $131,008,000 | +$17,295,722 | -$34,003,054 | -$16,707,332 | AABA, VER, ACHC, GOOG, KORS | Restatement | 19 Mar 2018, 10:38 |
| Q3 2017 | 18 | $146,553,000 | +$20,126,727 | -$9,055,103 | +$11,071,624 | AABA, IWM, VER, GOOG, GLD | 13F-HR | 14 Nov 2017, 14:36 |
| Q2 2017 | 18 | $117,772,000 | +$82,914,748 | -$64,487,739 | +$18,427,009 | AABA, VER, GOOG, FRGI, CHTR | 13F-HR | 14 Aug 2017, 15:57 |
| Q1 2017 | 14 | $95,500,000 | +$4,538,791 | -$3,427,572 | +$1,111,219 | YHOO, VER, GOOG, FRGI, NVCR | 13F-HR | 15 May 2017, 16:26 |
| Q4 2016 | 14 | $85,047,000 | +$8,541,254 | -$24,432,432 | -$15,891,178 | YHOO, VER, FRGI, GOOG, NVCR | Restatement | 17 Feb 2017, 15:14 |
| Q3 2016 | 16 | $108,478,000 | +$18,431,950 | -$6,557,982 | +$11,873,968 | YHOO, FRGI, NVCR, VER, GOOG | 13F-HR | 14 Nov 2016, 13:55 |
| Q2 2016 | 12 | $86,966,000 | +$9,044,033 | -$21,449,752 | -$12,405,719 | YHOO, VER, BJRI, GOOG, GLD | 13F-HR | 12 Aug 2016, 14:33 |
| Q1 2016 | 13 | $96,375,000 | +$42,772,161 | -$21,740,000 | +$21,032,161 | YHOO, HYG, VER, BJRI, GLD | 13F-HR | 13 May 2016, 11:37 |
| Q4 2015 | 14 | $70,263,000 | +$12,580,617 | -$34,292,325 | -$21,711,708 | YHOO, American Realty 3.75%, VER, SATS, GOOG | 13F-HR | 12 Feb 2016, 13:23 |
| Q3 2015 | 30 | $89,116,000 | +$26,941,859 | -$19,283,039 | +$7,658,820 | YHOO, American Realty 3.75%, VER, HP, SATS | 13F-HR | 13 Nov 2015, 13:44 |
| Q2 2015 | 28 | $96,183,000 | +$37,038,504 | -$17,791,222 | +$19,247,282 | YHOO, American Realty 3.75%, T104PS, SATS, BKS | 13F-HR | 13 Aug 2015, 16:27 |
| Q1 2015 | 29 | $75,343,000 | +$22,644,138 | -$9,463,718 | +$13,180,420 | American Realty 3.75%, PAH, MKL, ASCMA, SNI | 13F-HR | 14 May 2015, 15:17 |
| Q4 2014 | 23 | $62,266,000 | +$21,267,499 | -$22,534,745 | -$1,267,246 | ASCMA, American Realty 3.75%, PAH, SATS, MKL | 13F-HR | 13 Feb 2015, 16:05 |
| Q3 2014 | 22 | $69,317,000 | +$10,640,198 | -$28,324,695 | -$17,684,497 | GOODRICH PETROL 5.00%, ASCMA, SATS, MKL, PAH | 13F-HR | 14 Nov 2014, 16:05 |
| Q2 2014 | 26 | $91,996,000 | +$22,952,732 | -$41,411,305 | -$18,458,573 | SATS, CPE, ASCMA, MKL, PAH | 13F-HR | 13 Aug 2014, 16:00 |
| Q1 2014 | 22 | $99,585,000 | +$10,442,860 | -$36,102,571 | -$25,659,711 | Goodrich Petroleum Corp 5%, SATS, ASCMA, CPE, MKL | 13F-HR | 14 May 2014, 16:20 |
| Q4 2013 | 24 | $125,961,000 | $0 | $0 | $0 | SATS, Goodrich Petroleum Corp 5%, ASCMA, MKL, MAR | 13F-HR | 13 Feb 2014, 16:05 |